• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • Member Portal
  • Find a Nephrologist
  • Go Global Network
IgA Nephropathy Foundation Logo
  • IgA Nephropathy Foundation Logo
  • About Us
        • MM About

          • About Us
          • Leadership Team
          • Board of Directors
          • Medical & Scientific Advisory Board
          • IgAN Go Global Network
        • MM About 2

          • Latest News, Media, and Tips
          • Our Partners
          • IgAN Ambassadors
          • Join The Newsletter
  • Events
        • Events

          • Calendar of Events
          • SPARK 2026
          • IgA Nephropathy Day
          • Rare Disease Day
          • Kidney Health + Nutrition Month
  • Resources
        • MM – Resource 1

          • What is IgAN
          • Diagnosis
          • Understanding Your Lab Results
          • Understanding Your Biopsy
          • Understanding blood pressure and your kidneys
          • Treatment Options
          • Kidney Transplant and Living Donation in IgA Nephropathy
        • MM – Resource 2

          • IgAN Info
          • Faces of IgAN
          • IgAN Risk Quiz
          • Asian IgAN Awareness Initiative
          • IgAN Cookbook
          • IgAN FAQs
        • MM – Resource 3

          • Support Options
          • Patient Aid
          • IgANCare Program
          • Patient + Care Partner Support
          • Learn About Insurance
          • The IgA Nephropathy Foundation Ambassador Program
          • Caregiver Resources
          • Pregnancy and Family Planning
        • MM – Resource 4

          • Learning & Resources
          • IgAN+ App
          • Tools & Resources
          • Mental Health
          • Podcasts
          • IgAN Nutrition
          • IgAN Recipes
          • The Foundation Pop-Up Store is Here — for 3 Weeks Only!
          • HCP Library
  • Research
        • MM Research

          • IgA Nephropathy Studies
          • IgA Nephropathy Research
          • Published Research Articles
        • MM Research 2

          • Clinical Trials
          • Considering a Clinical Trial?
          • View All Clinical Trials
  • Join
        • MM – Join 1

          • Become a Member
          • The IgA Nephropathy Foundation Ambassador Program
          • Ways to Give
          • Advocacy for IgAN
        • MM – Join 2

          • Join Our Newsletter
          • Patient Registry
  • Donate
  • IgANCare Program

The IgAN Team

Turning a Personal Diagnosis into Community Impact.

March 25, 2026

Andrea’s Story For Andrea, IgA Nephropathy is not just a cause she supports, it is something she lives with every single day. This Kidney Awareness Month, Andrea Stup is channeling …

Category: Advocacy, News & Media
Read moreTurning a Personal Diagnosis into Community Impact.

Patient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy

March 10, 2026

We are proud to recognize Whitney Simmons and Kelly Chen, two incredible women serving on our Medical and Scientific Advisory Board (MSAB). Not only are they dedicated healthcare professionals, they …

Category: News & Media
Read morePatient and Provider Perspectives on the Patient Journey in Immunoglobulin A Nephropathy

Danielson to advance IgA Nephropathy awareness across Iowa—and abroad

August 25, 2025

When diagnosed with a rare disease, patients can find hope by connecting with people who understand their experience. Many patient-centered organizations address this need by providing community, education, and advocacy …

Category: Advocacy, News & MediaTag: ambassador
Read moreDanielson to advance IgA Nephropathy awareness across Iowa—and abroad

Travere and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgAN

February 23, 2024

SAN DIEGO, Feb. 23, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) and CSL Vifor today announced that the European Medicines Agency’s (EMA) CHMP has recommended approval of sparsentan for the treatment …

Category: News & MediaTag: IgA Nephropathy, igan treatment, iganephropathy
Read moreTravere and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgAN

Novartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)

December 21, 2023

Ad hoc announcement pursuant to Art. 53 LR Read full press release here

Category: News & Media
Read moreNovartis investigational iptacopan Phase III study demonstrates clinically meaningful and statistically significant proteinuria reduction in patients with C3 glomerulopathy (C3G)

Calliditas Therapeutics announces full FDA approval of TARPEYO®

December 20, 2023

On December 20, 2023, TARPEYO received full FDA approval for the new indication to reduce the loss of kidney function in adults with IgA Nephropathy (IgAN) who are at risk …

Category: News & Media
Read moreCalliditas Therapeutics announces full FDA approval of TARPEYO®
Controlling Blood Pressure With Kidney-Disease

8 Tips for taking control of your blood pressure 

November 16, 2023

The best way to slow the progression of IgA Nephropathy from high blood pressure is to take steps to control it. 1: Take your medicine every day as directed Most …

Category: Tips & Tricks
Read more8 Tips for taking control of your blood pressure 

Improving Patient-Provider Communications in IgA Nephropathy.

October 27, 2023

We want to tell you about an important research collaboration between IgA Nephropathy Foundation and the National Kidney Foundation (NKF). This research will have two phases. First, separate surveys of …

Category: News & MediaTag: IgA Nephropathy
Read moreImproving Patient-Provider Communications in IgA Nephropathy.

IgAN Cookbook and Aware Day Press Release

May 12, 2023

The IgA Nephropathy Foundation Launches First-Ever Cookbook Ahead of IgAN Awareness Day The Second Annual ‘IgAN Aware Day’ brings attention to the need for earlier diagnosis and treatments; cookbook offers …

Category: News & Media
Read moreIgAN Cookbook and Aware Day Press Release

6 Tips for Doing Your Own Research

August 1, 2022

It’s hard not to want to do your own research after learning you have a health condition like IgA Nephropathy. And while you should feel empowered to do your own …

Category: Tips & Tricks
Read more6 Tips for Doing Your Own Research

Thinking About What You Want From Treatment

August 1, 2022

When it comes to making a treatment decision for IgA Nephropathy, focusing on your priorities is important. Asking yourself “What do I most want to achieve from treatment?”, “How will …

Category: Resources
Read moreThinking About What You Want From Treatment

Understanding Your Treatment Options

July 13, 2022

Factors that  can shape treatment decisions Your provider might use a calculator of sorts to plug in information and help determine how quickly your condition may progress. This can also …

Category: Resources
Read moreUnderstanding Your Treatment Options
  • Page 1
  • Page 2
  • Next
Donate
  • Facebook
  • Twitter
  • Instagram
  • YouTube

Quick Links

  • About Us
  • Financials
  • Research
  • Contact Us
  • Join Our Efforts
  • Privacy Policy

Contact Us

(848) 298-4618

PO Box 1322 Wall, NJ 07719

© 2026 All Rights Reserved.

IgAN Foundation Newsletter

Subscribe to our newsletter below!

First Name
Last Name
Enter your email address

No thanks, I’m not interested!

References

  • Hall, Y.N., Fuentes, E.F., Chertow, G.M. et al. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol 5, 10 (2004). https://doi.org/10.1186/1471-2369-5-10
  • Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, et al. (2012) Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis. PLoS Genet 8(6): e1002765. doi:10.1371/journal.pgen.1002765